Cor Vasa 2012, 54(5-6):307-308

Nebivolol v léčbě kardiovaskulárních onemocnění

Prof. MUDr. Jiří Widimský jr., CSc.
Centrum pro výzkum, diagnostiku a léčbu arteriální hypertenze, III. interní klinika, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha

Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J. Nebivolol v léčbě kardiovaskulárních onemocnění. Cor Vasa. 2012;54(5-6):307-308.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cleophas TJ. Experimental evidences of selective antagonistic action of nebivolol on beta 1 adrenergic receptors. J Clin Med 1998;2:2-8.
    2. Špinarová L. Nebivolol. Farmakoterapie 2006;2:140-4.
    3. Van Bortel LM, de Hoon JN, Kool MJ, Wijnen JA, Vertommen CI, Van Nueten LG. Pharmacological properties of nebivolol in man. Eur J Clin Pharmacol 1997;51:379-84. Go to original source... Go to PubMed...
    4. Cleophas TJ, Grabowsky I, Menco G, et al. Long-term efficacy of nebivolol monotherapy in patients with hypertension. Curr Therap Res 2001;62:451-61. Go to original source...
    5. Nodari S, Mehra M, Dei Cas L. Beta blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized comparison of the long-term effects of atenolol vs nebivolol. Eur J Heart Fail 2003;5:621-7. Go to original source... Go to PubMed...
    6. Kampus P, Serg M, Kals J, Zagura M, Muda P, Karu K, et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 2011;57:1122-8. Go to original source... Go to PubMed...
    7. Tzemos N, Lim PO, MacDonald TM. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 2001;104:511-4. Go to original source... Go to PubMed...
    8. Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, et al. Comparative effects of nebivolol and atenolol on insulin sensitivity in hypertensive subjects with type II diabetes. J Hum Hypertens 1997;11:753-7. Go to original source... Go to PubMed...
    9. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-25. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes